financetom
Business
financetom
/
Business
/
Hydro One Prices $1.1 Billion Medium Term Notes Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hydro One Prices $1.1 Billion Medium Term Notes Offering
Aug 21, 2025 4:38 AM

07:06 AM EDT, 08/21/2025 (MT Newswires) -- Hydro One ( HRNNF ) overnight Wednesday said it has priced a $1.1 billion offering of medium term notes, which will be issued in line with the company's Sustainable Financing Framework.

The offering consists of $450 million of 3.94% notes due 2032, $300 million of 4.30% notes due 2035, and $350 million of 4.95% notes due 2055. The notes will be issued at prices ranging from $99.907 to $99.988 per $100 principal amount, a statement said.

The offering is expected to close on August 25. Proceeds will initially be used to pay down debt and may also be allocated to eligible green projects.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sun Life quarterly profit rises on strong growth in Canada and Asian region
Sun Life quarterly profit rises on strong growth in Canada and Asian region
Aug 12, 2024
Aug 12 (Reuters) - Sun Life Financial ( SLF ), Canada's second-biggest life insurer, reported an 8.7% rise in second-quarter profit on Monday, boosted by strong growth at home and in the Asian region. The company's underlying net income was C$1 billion ($727.59 million) in the three months ended June 30, or C$1.72 per share, compared to C$920 million, or...
Syros Pharmaceuticals Ends Trial of Prospective Acute Myeloid Leukemia Treatment -- Shares Plunge
Syros Pharmaceuticals Ends Trial of Prospective Acute Myeloid Leukemia Treatment -- Shares Plunge
Aug 12, 2024
05:10 PM EDT, 08/12/2024 (MT Newswires) -- Syros Pharmaceuticals ( SYRS ) was plunging 67% in Monday after-hours session after saying it will stop enrolling new patients for a phase 2 trial of tamibarotene for acute myeloid leukemia with RARA gene overexpression after an interim analysis suggested the probability for success was low. The trial was studying tamibarotene with a...
Invesco Assets Under Management Rise 0.9% in July
Invesco Assets Under Management Rise 0.9% in July
Aug 12, 2024
05:09 PM EDT, 08/12/2024 (MT Newswires) -- Invesco ( IVZ ) reported late Monday that its preliminary assets under management rose 0.9% month-on-month to $1.732 trillion at the end of July. The company said favorable market returns increased AUM by $9 billion, while foreign exchange increased AUM by $4.9 billion. ...
Western Midstream Says Occidental Affiliates Launch Secondary Unit Offering; Shares Fall After Hours
Western Midstream Says Occidental Affiliates Launch Secondary Unit Offering; Shares Fall After Hours
Aug 12, 2024
05:10 PM EDT, 08/12/2024 (MT Newswires) -- Western Midstream Partners ( WES ) said late Monday that Occidental (OXY) affiliates have launched a secondary public offering of 19 million Western Midstream ( WES ) common units representing limited partner interests in the company. The selling unit holders plan to grant a 30-day overallotment option to the underwriter to acquire up...
Copyright 2023-2026 - www.financetom.com All Rights Reserved